<--- Back to Details
First PageDocument Content
Medicine / Acute intermittent porphyria / Hereditary coproporphyria / Erythropoietic porphyria / Variegate porphyria / Porphyrin / Erythropoietic protoporphyria / Gunther disease / Porphobilinogen / Porphyrias / Health / Chemistry
Date: 2007-02-05 17:50:53
Medicine
Acute intermittent porphyria
Hereditary coproporphyria
Erythropoietic porphyria
Variegate porphyria
Porphyrin
Erythropoietic protoporphyria
Gunther disease
Porphobilinogen
Porphyrias
Health
Chemistry

Add to Reading List

Source URL: www.biomed.cas.cz

Download Document from Source Website

File Size: 345,22 KB

Share Document on Facebook

Similar Documents

Medicine / Health / Clinical medicine / Rare diseases / Porphyrias / Lysosomal storage diseases / RTT / Erythropoietic protoporphyria / Glycogen storage disease type II / Disease

How one patient with a rare disease coped with his genetic disorder

DocID: 1r9mW - View Document

Peptides / Peptide hormones / Afamelanotide / Porphyrias / Erythropoietic protoporphyria / Melanocyte-stimulating hormone / EPP / Carotene / Sunless tanning

Microsoft PowerPoint - OrphanDrugs_Genf2015_Barman_Falchetto [Kompatibilitätsmodus]

DocID: 1ooCQ - View Document

Erythropoietic protoporphyria / Porphyrias / Epp

Review of the Environmental Protection (Kwinana) (Atmospheric Wastes) Policy 1999 An Environmental Protection Policy (EPP) is a mechanism for the protection of any portion of the environment or prevention/control of poll

DocID: 17FN4 - View Document

Erythropoietic protoporphyria / Porphyrias

Position DescriptionComplete for Executive Services Positions ONLY)

DocID: 12Xwl - View Document

Erythropoietic protoporphyria / Porphyrias / Epp

“Enhanced Productivity Programme: [removed]” Booklet Report on EPP savings -- Information Technology Services Department Total value of EPP Savings: $6.685m, equivalent to 1% of total Recurrent Baseline Expenditure in

DocID: ZCT9 - View Document